Brainomix 360 Hyperdensity
Brainomix Limited
Authorized purpose: Provides volumetric hyperdensity segmentation and quantification as an aid; physicians must review original images.
- Modality
- CT/CTA
- Anatomy
- Brain
- Decision
- 2026-06-12
Vendor
8 FDA submission entries in this directory. This is not a count of distinct commercial offers.
Claim vendor profileEach entry is an FDA submission, not a distinct commercial offer. Inspect the exact record before comparing evidence, asking for a quote or planning an integration.
Prepare with a buyer guide:
Clinical guide links appear when this list contains a current reviewed example. They do not classify or endorse the other entries. All buyer guides · Compare exact records · Documented families
Brainomix Limited
Authorized purpose: Provides volumetric hyperdensity segmentation and quantification as an aid; physicians must review original images.
Brainomix Limited
Authorized purpose: Triage and notification of suspected intracranial hemorrhage or anterior-circulation LVO on acute non-contrast head CT; not primary diagnosis.
Brainomix Limited
Authorized purpose: Brainomix 360 e-ASPECTS registers adult non-contrast brain CT, segments ASPECTS regions, and provides an editable ASPECTS score with highlighted regions and voxel contribution views to assist trained clinicians evaluating suspected ischemic stroke within 24 hours of last known well.
Brainomix Limited
Authorized purpose: Brainomix 360 e-CTA analyzes adult CTA brain DICOM for vessel visualization and post-processing, including MCA vessel-density asymmetry, contrast/phase context, overlays, and MIP views, for trained clinical review; it is not for mobile diagnosis and its vessel-density asymmetry ratio is limited to the MCA region.
Brainomix Limited
Authorized purpose: Analyze non-contrast head CT images to help hospital networks and trained clinicians triage and prioritize suspected positive findings for intracranial ICA/M1 large-vessel occlusion and intracranial hemorrhage in adults in the acute setting within 24 hours of symptom onset or, when unclear, since last known well; the device is not a primary diagnostic device or rule-out device.
Brainomix Limited
Authorized purpose: Notification-only, parallel triage of acute-setting brain CTA studies for suspected large-vessel occlusion (LVO), communicating cases to a neurovascular specialist for review; not diagnostic.
Brainomix Limited
Authorized purpose: Provide notification-only parallel workflow triage of adult non-contrast brain CT studies acquired in the acute setting within 24 hours of symptom onset or since last known well when onset is unclear, notifying a specialist when intracranial hemorrhage is suspected.
Brainomix Limited
Authorized purpose: Assists clinician assessment of brain abnormalities and ischemic injury by generating an automated ASPECTS score for known MCA/ICA occlusion cases.